This website uses cookies to:

  • Collect anonymous data with Google Analytics to help us learn which parts of the website are the most useful.
  • Prevent this box from annoying you for a while once you've agreed to dismiss it.

By using this site, you are agreeing to the use of these cookies.

Dismiss this message
Bridgend Clinic logo

Consultant Details:


#

Dr Aaron Wong

Consultant Cardiologist


Qualificiations

MBChB, MRCP (UK), Doctorate of Medicine (MD)


Speciality

Primary Specialities: Cardiology and General Medicine


Special Clinical Interests

  • Investigations and Management of complex Heart Failure
  • Stress Echocardiography
  • Transoesophageal Echocardiography
  • Coronary angiography and assessment of cardiac haemodynamics.


Research Interests

  • Heart Failure and Diabetes
  • Cardiac and metabolic biomarkers.
  • Endothelial Function
  • Cardiopulmonary exercise testing


Current NHS and/or university posts

  • Consultant Cardiologist and General Physician, Princess of Wales Hospital
  • Honorary Lecturer, University of Cardiff


Year of Qualification

University of Glasgow, 2001


Memberships

  • British Cardiovascular Society
  • British Society of Echocardiography
  • Royal College of Physician, London
  • European Society of Heart Failure


Information

Dr Wong qualified from University of Glasgow in 2001. He completed his medical rotations in various hospitals in Glasgow and completed his MRCP (UK) in 2004. He worked as a locum oncology registrar for 6 months before taking up a Cardiology Research Fellow post in University of Dundee. He was the principle investigator of a British Heart Foundation funded research project TAYSIDE trial (The Effects of Metformin on exercise capacity in insulin resistant chronic heart failure). His research topic was “Insulin Resistance, Chronic Heart Failure and potential treatment modalities”. He was also co-investigator of two international multicenter clinical trials. He completed his higher specialty training in cardiology and general medicine in Wales in 2014.

He has published several papers on insulin resistance and heart failure and presented on numerous occasions in local, national and international meetings.

He is currently the principle investigator of an international multicenter clinical trial in Princess of Wales Hospital examining the new heart failure drug- Entresto, in patients admitted with heart failure.

General Enquiries:


Consultations from just £80

Consultations from just £80

Consultations from just £80